Connect

Start a conversation

For business, partnering, or general inquiries, please reach out through the contact form. CinPressa welcomes discussions with partners interested in advancing a differentiated AGT-targeting siRNA for hypertension.

Parent company

CinRx Pharma · Cincinnati, Ohio, USA

Send us a message

Inquiries are routed to the team that can answer them. We reply within two business days.

Your details

Your inquiry

Your details are used only to answer this inquiry.

Let’s advance medicine, together.

Stay connected with CinPressa

For partnering, investment, or general inquiries, connect with the team through our Contact page.

CinPressapharma

Advancing a best-in-class, long-acting AGT siRNA (CIN-111) for a durable backbone of blood pressure control.

Parent company

© 2026 CinPressa Pharma. All rights reserved.

A CinRx Pharma portfolio company